Niu Cuili, Bai Xiaowei, Gui Xiuyin, Liang Yuanzhe, Zhang Ling
Department of Gynecology, Xingtai Third Hospital, Xingtai, Hebei Province, China.
J Minim Access Surg. 2025 Jan 1;21(1):39-45. doi: 10.4103/jmas.jmas_350_23. Epub 2024 Jul 30.
We aimed to develop and validate a predictive score to estimate the post-operative recurrence risk after laparoscopic excision of ovarian endometrioma (OMA).
The prediction score was developed using a training set comprising 431 patients with OMA who underwent laparoscopic surgery at our institution between January 2015 and September 2017. A follow-up period of at least 5 years was required. Clinical data were entered into least absolute shrinkage and selection operator (LASSO) regression to build a scoring system that predicted OMA recurrence. A testing set containing 185 patients from October 2017 to October 2018 was used to assess its performance.
Based on LASSO regression, the final score (ACSAP score) included five clinical predictors (0-15 points): Age, cyst size, previous surgery for OMA, revised American Society for Reproductive Medicine stage and post-operative pregnancy. The area under the curve values of the score were 0.741 (0.765) and 0.727 (0.795) for predicting 3-year and 5-year OMA recurrence, respectively, in the training (testing) set. The score stratified patients into three risk groups in both sets, with significant differences in the 5-year recurrence rates (low-risk, 5.3% [0%]; intermediate-risk, 20.2% [16.5%] and high-risk, 48.0% [36.5%]; P < 0.001). Moreover, patients in the intermediate- and high-risk groups exhibited a significant reduction in the 5-year cumulative recurrence following a minimum of 15-month post-operative medical treatment (both P < 0.05).
The ACSAP score may be a concise and useful tool for identifying patients with a higher risk of OMA recurrence after surgery who might receive long-term post-operative medical treatment.
我们旨在开发并验证一种预测评分,以估计腹腔镜切除卵巢子宫内膜异位囊肿(OMA)后的术后复发风险。
使用一个训练集来制定预测评分,该训练集包含2015年1月至2017年9月期间在我院接受腹腔镜手术的431例OMA患者。需要至少5年的随访期。将临床数据输入最小绝对收缩和选择算子(LASSO)回归,以建立预测OMA复发的评分系统。使用一个包含2017年10月至2018年10月期间185例患者的测试集来评估其性能。
基于LASSO回归,最终评分(ACSAP评分)包括五个临床预测因素(0 - 15分):年龄、囊肿大小、既往OMA手术史、修订后的美国生殖医学学会分期和术后妊娠情况。在训练(测试)集中,该评分预测3年和5年OMA复发的曲线下面积值分别为0.741(0.765)和0.727(0.795)。该评分在两个数据集中均将患者分为三个风险组,5年复发率存在显著差异(低风险组,5.3% [0%];中风险组,20.2% [16.5%];高风险组,48.0% [36.5%];P < 0.001)。此外,中风险组和高风险组的患者在术后至少接受15个月的药物治疗后,5年累积复发率显著降低(均P < 0.05)。
ACSAP评分可能是一种简洁且有用的工具,用于识别术后OMA复发风险较高、可能需要接受长期术后药物治疗的患者。